My previous investment thought on Dillard’s (NYSE: DDS ) was a sell rating because I expected EPS to continue seeing pressure, especially as sales fall and margins contract. After reviewing 2Q25, I am shifting myI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimate ...